sulfasalazine has been researched along with Lung Diseases, Interstitial in 7 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present a case of a patient with drug-induced hypersensitivity syndrome (DIHS) caused by salazosulfapyridine combined with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) caused by interstitial pneumonia (IP)." | 1.51 | A case of drug-induced hypersensitivity syndrome induced by salazosulfapyridine combined with SIADH caused by interstitial pneumonia. ( Abe, I; Hanada, H; Higashi, T; Inoue, R; Kurihara, K; Minamikawa, T; Mitsutake, T; Morinaga, Y; Nii, K; Sakamoto, K; Tsugawa, J; Ueda, Y, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morinaga, Y | 1 |
| Abe, I | 1 |
| Minamikawa, T | 1 |
| Ueda, Y | 1 |
| Nii, K | 1 |
| Sakamoto, K | 1 |
| Inoue, R | 1 |
| Mitsutake, T | 1 |
| Hanada, H | 1 |
| Tsugawa, J | 1 |
| Kurihara, K | 1 |
| Higashi, T | 1 |
| Wada, Y | 1 |
| Kobayashi, D | 1 |
| Murakami, S | 1 |
| Oda, M | 1 |
| Hanawa, H | 1 |
| Kuroda, T | 1 |
| Nakano, M | 1 |
| Narita, I | 1 |
| Uittenbogaart, SB | 1 |
| Klemt-Kropp, M | 1 |
| Sugii, S | 1 |
| Peters, FP | 1 |
| Engels, LG | 1 |
| Moers, AM | 1 |
| Sacks, R | 1 |
| Marvisi, M | 1 |
| Fornasari, G | 1 |
2 reviews available for sulfasalazine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
[Adverse effects of DMARDs in treatment of rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Female; Gold Sodium Thiomalate; Hematologic Diseases; H | 2005 |
[Is the lung a target organ in inflammatory bowel disease?].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchial Diseases | 2001 |
5 other studies available for sulfasalazine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
A case of drug-induced hypersensitivity syndrome induced by salazosulfapyridine combined with SIADH caused by interstitial pneumonia.
Topics: Aged; Cytomegalovirus Infections; Drug Eruptions; Exanthema Subitum; Humans; Inappropriate ADH Syndr | 2019 |
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazo | 2011 |
[Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans; Lung Diseases, Inters | 2011 |
Pneumonitis induced by sulphasalazine.
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Lung Diseases, Interstitial; Sulfasalazine | 1997 |
Is the cure worse than the disease?
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Lung Diseases, Interstitial; Male; Sulfasalazin | 2001 |